| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |